PLEOMORPHIC LIPOSARCOMA
Clinical trials for PLEOMORPHIC LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new PLEOMORPHIC LIPOSARCOMA trials appear
Sign up with your email to follow new studies for PLEOMORPHIC LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to halt aggressive fat tissue cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, mirdametinib and palbociclib, is safe and effective for people with advanced liposarcoma that has spread, returned, or cannot be surgically removed. Researchers will first find the safest dose of mirdametinib to give with a fixed…
Matched conditions: PLEOMORPHIC LIPOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for tough cancers: trial tests Immune-Boosting drug with chemo
Disease control Recruiting nowThis study is testing whether adding a new immunotherapy drug called tislelizumab to standard chemotherapy works better for people with advanced soft tissue sarcoma. It will enroll 45 adults with specific types of sarcoma that cannot be removed by surgery or have spread. The main…
Matched conditions: PLEOMORPHIC LIPOSARCOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Mar 17, 2026 13:10 UTC
-
Proton beam trial aims to zap inoperable tumors with higher, safer doses
Disease control Recruiting nowThis study is testing whether a newer type of radiation therapy, called proton beam therapy, can be given at a higher dose to better control inoperable soft tissue sarcomas. The goal is to see if this approach stops tumor growth for at least two years without increasing side effe…
Matched conditions: PLEOMORPHIC LIPOSARCOMA
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC